| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/23/2014 | US8916149 Preventing and treating sepsis |
| 12/23/2014 | US8916148 Tissue plasminogen activator variant uses |
| 12/23/2014 | US8916146 Treatment of inflammatory diseases using placental stem cells |
| 12/23/2014 | US8916144 Proangiogenic compositions, method for preparing same, and uses thereof |
| 12/23/2014 | US8916143 Polymer compositions of dihydroxyacetone and uses thereof |
| 12/23/2014 | DE202014007740U1 Arznei- oder Nahrungsergänzungsmittel zur Behandlung und/oder Prophylaxe von Gelenkbeschwerden, Knochenerkrankungen sowie Zellendegeneration und Demenz ( SmartAger® ) Drugs, or dietary supplements for the treatment and / or prevention of joint pain, bone and cell degeneration and dementia (SmartAger®) |
| 12/19/2014 | DE202014007438U1 Flüssige Applikation von Verdauungsenzymen Cash and application of digestive enzymes |
| 12/18/2014 | US20140371712 Convection enhanced delivery apparatus, method, and application |
| 12/18/2014 | US20140371687 Device having titania nanotube membrane for drug delivery |
| 12/18/2014 | US20140371425 Use of c1-inhibitor for the treatment of secondary edema of the central nervous system |
| 12/18/2014 | US20140371423 Method for purification of micafungin |
| 12/18/2014 | US20140371422 Methods for manufacturing an antifungal agent |
| 12/18/2014 | US20140371159 In vitro method for modifying the depletion profile of treg cells present in a total splenocyte population of a biological sample by means of the isolation, culturing and exposure thereof to an atp and polymixin b medium |
| 12/18/2014 | US20140371158 Beauvericin compositions and methods thereof for inhibiting the hsp90 chaperone pathway |
| 12/18/2014 | US20140371157 Methods of downregulating translocated oncogene expression using bromodomain inhibitors |
| 12/18/2014 | US20140371153 Method for administering omega-conopeptide |
| 12/18/2014 | US20140371151 Use of Liposomal WNT Composition to Enhance Osseointegration |
| 12/18/2014 | US20140371150 Peptides targeting receptor activator of nuclear factor - kappa b (rank) and their applications |
| 12/18/2014 | US20140371149 Scarring reducing wound treatment |
| 12/18/2014 | US20140371147 Combination of a prostaglandin receptor agonist and an mc1r receptor agonist for the treatment and/or prevention of pigmentation disorders |
| 12/18/2014 | US20140371145 Scaffold for vascular endothelial cell migration |
| 12/18/2014 | US20140371141 Insulin glargine/lixisenatide fixed ratio formulation |
| 12/18/2014 | US20140371139 Preparations containing amorphous emodepside |
| 12/18/2014 | US20140371138 Inhibitors of hepatitis c virus replication |
| 12/18/2014 | US20140371136 Growth hormone polypeptides and methods of making and using same |
| 12/18/2014 | US20140371135 High purity lipopeptides |
| 12/18/2014 | US20140371134 Dry Pharmaceutical Compositions for Topical Delivery of Oral Medications, Nasal Delivery and to Treat Ear |
| 12/18/2014 | US20140371133 Methods of treating chronic disorders with complement inhibitors |
| 12/18/2014 | US20140371130 Use of a holotoxin to reduce endoplasmic reticulum-associated degradation of misfolded proteins |
| 12/18/2014 | US20140371085 T cell receptor display |
| 12/18/2014 | US20140370094 Silk-based scaffold platform for engineering tissue constructs |
| 12/18/2014 | US20140370087 Novel use of angiogenin |
| 12/18/2014 | US20140370082 Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 12/18/2014 | US20140370060 Tear Film Stability |
| 12/18/2014 | US20140370039 Il-12 immunotherapy for cancer |
| 12/18/2014 | US20140370038 Cd4+ cd25+ t-cells activated to a specific antigen |
| 12/18/2014 | US20140370036 COMPOSITIONS OF, AND METHODS FOR, ALPHA-1 ANTITRYPSIN FcFUSION MOLECULES |
| 12/18/2014 | US20140370035 Methods of reducing immunogenicity against factor viii in individuals undergoing factor viii therapy |
| 12/18/2014 | US20140370027 Inhibition of macrophage-synthesized wnt7b to inhibit tumor angiogenesis and metastasis |
| 12/18/2014 | US20140370025 Uses of mammalian cytokines and agonists; related reagents |
| 12/18/2014 | US20140369997 Pharmaceutical composition for a foaming eye drop |
| 12/18/2014 | US20140369996 Chymosin for the Prevention and Treatment of Gastrointestinal Disorders |
| 12/18/2014 | US20140369995 Combination therapy for treatment of patients with neurological disorders and cerebral infarction |
| 12/18/2014 | US20140369993 Stabilised protein compositions based on semifluorinated alkanes |
| 12/18/2014 | US20140369992 C-Terminally Tethered Amino Acids and Their Fibrinolytic Therapeutic Uses |
| 12/18/2014 | US20140369991 Formulations for Wound Therapy |
| 12/18/2014 | US20140369990 Targeted antimicrobials and related compositions, methods and systems |
| 12/18/2014 | US20140369988 Novel Toxin-Antitoxin System |
| 12/18/2014 | US20140369987 Dermaseptin b2 used as an inhibitor of the growth of a tumor |
| 12/18/2014 | US20140369984 Biomaterial for articular cartilage maintenance and treatment of arthritis |
| 12/18/2014 | US20140369979 Vector simultaneously expressing dodecameric trail and hsv-tk suicide genes, and anticancer stem cell therapeutic agent using same |
| 12/18/2014 | US20140369971 Method and composition for inducing human pluripotent stem cells |
| 12/18/2014 | US20140369964 Glycosylated polypeptide and pharmaceutical composition containing same |
| 12/18/2014 | US20140369963 Methods for the treatment of hepatitis b and hepatitis d infections |
| 12/18/2014 | US20140369962 Methods for the treatment of hepatitis b and hepatitis d infections |
| 12/18/2014 | US20140369958 Il-12 for radiation protection and radiation-induced toxicity mitigation |
| 12/18/2014 | US20140369957 Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins c3a/c4a, immunoglobulins and chemotactic factors |
| 12/18/2014 | US20140369930 Cyclotides as immunosuppressive agents |
| 12/17/2014 | CN104220461A 天冬氨酰-tRNA合成酶-FC缀合物 Aspartyl -tRNA synthase -FC conjugates |
| 12/17/2014 | CN104220452A 用于治疗心力衰竭的合成的apelin模拟物 Apelin synthetic mimetics for the treatment of heart failure |
| 12/17/2014 | CN104220098A 用于心血管疾病和其它病况的旁分泌基因的全身性递送和受调节的表达 Systemic cardiovascular disease and other conditions for paracrine delivery and gene expression regulated by the |
| 12/17/2014 | CN104220088A 酶组合物及其用于创伤愈合的用途 The enzyme composition for use in wound healing and their use |
| 12/17/2014 | CN104220087A 用于治疗核酸相关眼病的组合物及方法 Nucleic acid-related eye disease treatment compositions and methods for |
| 12/17/2014 | CN104220086A Peg化的c-肽 Peg of c- peptide |
| 12/17/2014 | CN104220085A 包含融合蛋白的癌症治疗用药物组合物 Fusion protein comprising the pharmaceutical composition for cancer treatment |
| 12/17/2014 | CN104220057A 药物组合物和方法 Pharmaceutical compositions and methods |
| 12/17/2014 | CN104220046A 用于生长因子多相释放的体系和方法 System and Method for multiphasic release growth factors |
| 12/17/2014 | CN104212861A 一种菲律宾蛤仔寡肽的制备方法及其在抗前列腺癌中的应用 Preparation method of Ruditapes oligopeptide and its application in anti-prostate cancer |
| 12/17/2014 | CN104212821A Bcr-abl融合蛋白突变体及其编码基因、表达载体及其构建方法和应用 Bcr-abl fusion protein and its encoding gene mutant expression vector construction method and application |
| 12/17/2014 | CN104212805A 一种家蚕抗菌肽attacin2及其异源表达和应用 One kind Cecropin attacin2 and heterologous expression and application |
| 12/17/2014 | CN104211816A 一种tat-pap融合蛋白及其制备方法和应用 One kind of tat-pap fusion protein and its preparation method and application |
| 12/17/2014 | CN104211814A 用于消耗靶膜蛋白的组合物 For the consumption of the target membrane protein composition |
| 12/17/2014 | CN104211802A 人凝血因子轻链蛋白及其应用 Human coagulation factor light chain protein and its application |
| 12/17/2014 | CN104211800A 组织损伤修复中的基质细胞衍生因子1的蛋白酶抗性突变体 Tissue injury and repair in the stromal cell derived factor-1 protease-resistant mutants |
| 12/17/2014 | CN104211799A 人源egf结构域蛋白及其应用 Human egf domain protein and its application |
| 12/17/2014 | CN104211795A 靶向钾离子通道Kvl.3活性多肽的分子设计及制备与应用 Design and preparation and application of targeted molecular potassium ion channel activity of the polypeptide Kvl.3 |
| 12/17/2014 | CN104211794A 一种家鸽Cathelicidin—Cl-CATH2肽及其基因、应用 One kind of pigeon Cathelicidin-Cl-CATH2 peptides and genes, application |
| 12/17/2014 | CN104211787A 用于结核病诊断和预防的蛋白 For TB diagnosis and prevention of protein |
| 12/17/2014 | CN104211781A 金黄色葡萄球菌裂解蛋白的制备方法及其应用 Preparation of Staphylococcus aureus protein cleavage and its application |
| 12/17/2014 | CN104211780A 一种环缩肽类化合物及其制备方法和用途 A cyclic peptide compounds shrink its preparation method and use |
| 12/17/2014 | CN104211779A 一种杂环棘孢肽类化合物及其制备方法和用途 Provided a heterocyclic aculeatus peptide compounds and preparation and use |
| 12/17/2014 | CN104211778A 一种转化生长因子e1激动剂多肽及其制备方法、应用 A transformed e1 agonist polypeptide growth factor and its preparation method, application |
| 12/17/2014 | CN104211772A 结直肠癌抗原肽与热休克蛋白的复合物及其应用 Of colorectal cancer antigen peptide and heat shock protein complexes and their application |
| 12/17/2014 | CN104211770A 神经胶质瘤相关肽和热休克蛋白形成的复合物及其应用 Glioma-related peptide complexes and the formation of heat shock proteins and their application |
| 12/17/2014 | CN104211767A 异喹啉-3-甲酰氨基酰寡肽，其制备，纳米结构，抗肿瘤活性和应用 Isoquinoline-3-formyl-amino acid oligopeptide, their preparation, nanostructures, antitumor activity and Applications |
| 12/17/2014 | CN104211766A 环六脂肽类化合物及其作为药物的用途 Ring six lipopeptides and their use as medicaments |
| 12/17/2014 | CN104211765A 与trb3蛋白特异性结合的多肽，其筛选方法、鉴定和用途 And trb3 protein specifically binds a polypeptide, which screening method, identification and uses |
| 12/17/2014 | CN104211764A N-(3S-四氢-e-咔啉-3-羰基）-M-GDV，其合成，纳米结构，抗血栓活性及应用 N- (3S- tetrahydro -e- carboline-3-carbonyl) -M-GDV, their synthesis, nanostructures, antithrombotic activity and application |
| 12/17/2014 | CN104211762A 饱和脂肪链醇，地塞米松和His-Gly-Lys的缀合物，其制备，纳米结构及应用 Chain aliphatic saturated alcohols, dexamethasone, and His-Gly-Lys conjugates, their preparation, and application of nanostructures |
| 12/17/2014 | CN104211761A 饱和脂肪链醇，地塞米松和His-Gly-Glu的缀合物，其制备，纳米结构及应用 Chain aliphatic saturated alcohols, dexamethasone, and His-Gly-Glu conjugates, their preparation, and application of nanostructures |
| 12/17/2014 | CN104211760A 饱和脂肪链醇，地塞米松和Glu-Asp-Gly的缀合物，其制备，纳米结构及应用 Chain aliphatic saturated alcohols, dexamethasone, and Glu-Asp-Gly conjugates, their preparation, and application of nanostructures |
| 12/17/2014 | CN104211759A 二甲氧羟苯基-13-咔啉-3-甲酰氨基酸衍生物，其制备，纳米结构，活性和应用 Dimethoxyphenyl hydroxyphenyl -13- carboline-3-carboxylic acid derivative, its preparation, nanostructures, and application activity |
| 12/17/2014 | CN104211756A 2-氨基-1,3-丙二醇衍生物，其制备，纳米结构，排铅活性和应用 2-amino-1,3-propanediol derivatives, their preparation, nanostructures, and application activity Excretion |
| 12/17/2014 | CN104211755A 一种畜禽血中生物活性肽BAPs的提取方法及生物活性肽BAPs和应用 An Animal blood extraction of bioactive peptides and bioactive peptides BAPs BAPs and applications |
| 12/17/2014 | CN104208720A PPP3CC基因或其表达产物在治疗j11崎病中的应用 PPP3CC gene or its expression product in the treatment of Kawasaki disease in j11 |
| 12/17/2014 | CN104208683A 一种抗鸭病毒性疾病的药物组合物、冻干粉、制备方法及应用 An anti-viral pharmaceutical composition duck, lyophilized powder, preparation method and application |
| 12/17/2014 | CN104208681A 一种抗鸭病毒性疾病的混合冻干粉及其制备方法 A hybrid method for the preparation of freeze-dried powder and duck viral resistance |
| 12/17/2014 | CN104208678A 一种兽用抗病毒组合物、冻干粉、制备方法及应用 One kind of veterinary antiviral composition, a lyophilized powder, preparation method and application |
| 12/17/2014 | CN104208675A 一种抗鸡病毒性疾病的混合冻干粉及其制备方法 Lyophilized powder mixing and its preparation method, an anti-viral chicken |
| 12/17/2014 | CN104208674A 一种抗猪病毒性疾病的混合冻干粉及其制备方法 Lyophilized powder mixing and its preparation method, an anti-viral disease of pigs |